Evidence map›Paper›PMID 35859177›Full record

ArticleNature2022

ADAR1 mutation causes ZBP1-dependent immunopathology.

Nicholas W Hubbard, Joshua M Ames, Megan Maurano, Lan H Chu, Kim Y Somfleth, Nandan S Gokhale, Margo Werner, Jessica M Snyder, Katrina Lichauco, Ram Savan and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 154 papers.

0numbers the graph read from it
0cells of the map it votes in
154citing papers in PubMed
16.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

154 citing papers in PubMed, 200 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Mechanisms, regulation and clinical relevance of necroptosis.Nature reviews. Molecular cell biology · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

94 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Nicholas W HubbardDepartment of Immunology, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-6322-4840
Joshua M Ames *Department of Immunology, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-9282-5637
Megan Maurano *Department of Immunology, University of Washington, Seattle, WA, USA.
Lan H ChuDepartment of Immunology, University of Washington, Seattle, WA, USA.
Kim Y SomflethDepartment of Immunology, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-9572-5172
Nandan S GokhaleDepartment of Immunology, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-4459-4053
Margo WernerDepartment of Immunology, University of Washington, Seattle, WA, USA.
Jessica M SnyderDepartment of Comparative Medicine, University of Washington, Seattle, WA, USA.
Katrina LichaucoDepartment of Immunology, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-9480-2893
Ram SavanDepartment of Immunology, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-3087-1355
Daniel B StetsonDepartment of Immunology, University of Washington, Seattle, WA, USA.
Andrew OberstDepartment of Immunology, University of Washington, Seattle, WA, USA. oberst@uw.edu.ORCID http://orcid.org/0000-0002-9500-7912
University of Washington · US

Funding

Intracellular nucleic acid detection in autoimmunityR01AI084914 · NIAID · UNIVERSITY OF WASHINGTON · PI STETSON, DANIEL B · 2010 to 2024
$7.2M
RESEARCH TRAINING IN RHEUMATOLOGYT32AR007108 · NIAMS · UNIVERSITY OF WASHINGTON · PI Shaun Jackson, Tomas M Mustelin · 1986 to 2026
$6.6M
ZBP1 activationR01AI153246 · NIAID · UNIVERSITY OF WASHINGTON · PI OBERST, ANDREW ATWELL · 2021 to 2025
$3.1M
Basic Training at the Intersection of Innate and Adaptive Immunity in DiseaseT32AI106677 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL, GOVERMAN, JOAN M · 2013 to 2022
$2.1M
Immune activation by necroptotic cell deathR01CA228098 · NCI · UNIVERSITY OF WASHINGTON · PI OBERST, ANDREW ATWELL · 2019 to 2023
$2.1M
Modulation of antiviral responses against influenza infection by long non-coding RNAsR21AI147177 · NIAID · UNIVERSITY OF WASHINGTON · PI SAVAN, RAM · 2019 to 2020
$514k
Translational Reprogramming by Regulatory T CellsR21AI143227 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI SAVAN, RAM, ZIEGLER, STEVEN F · 2019 to 2020
$487k
NCI NIH HHS R01 CA228098NIAID NIH HHS R01 AI084914NIAID NIH HHS R01 AI153246NIAID NIH HHS R21 AI143227NIAID NIH HHS R21 AI147177NIAID NIH HHS T32 AI106677NIAMS NIH HHS T32 AR007108NIH HHS R01 AI147177
6 · The paper itself

Abstract

The RNA-editing enzyme ADAR1 is essential for the suppression of innate immune activation and pathology caused by aberrant recognition of self-RNA, a role it carries out by disrupting the duplex structure of endogenous double-stranded RNA species

Indexed as

Adenosine DeaminaseImmune System DiseasesInflammationMutationRNA-Binding ProteinsAnimalsCaspase 8Cell DeathGene DeletionMammalsProtein KinasesReceptor-Interacting Protein Serine-Threonine KinasesRNA, Double-StrandedSignal TransductionAdenosine DeaminaseCaspase 8Protein KinasesReceptor-Interacting Protein Serine-Threonine KinasesRNA-Binding ProteinsRNA, Double-Stranded

Identifiers

PMID35859177
PMCPMC9339495
OpenAlexW4286209651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.